NeuroSearch A/S said the results of a meta-analysis with its Huntexil treatment for Huntington’s disease support the conclusions drawn from each individual trial, with better precision due to the larger number of observations.
Better-educated Americans increasingly live longer than everyone else, and children from higher-income families in the U.S. are getting more education than other people. These are two of the most disturbing trends in the U.S., and it’s entirely plausible that they are related.
Over the past decade, we have heard about the “fat gene,” the “diabetes gene,” the “alcoholism gene,” the “intelligence gene,” even the “God gene.” In the end, none of these so-called discoveries proved correct.
A prenatal test that analyzes a mother’s blood and father’s saliva may one day be all it takes to check a fetus for genetic illnesses, replacing one that requires drawing fluid from the uterus, a study suggests.
GlaxoSmithKline Plc , the U.K.’s largest drugmaker, bolstered efforts to discover treatments for rare diseases with a partnership focused on a genetic disorder that affects about 350 children worldwide.
Teva Pharmaceutical Industries Ltd. will focus drug-development efforts under new Chief Executive Officer Jeremy Levin on respiratory and central nervous system illnesses as the company seeks to replace medicines set to lose patent protection in the next three years.